MedPath

LYOPHILIZED PEGASPARGASE

Lyophilized Pegaspargase (750 U/mL) Export Only

Approved
Approval ID

95b28db2-479c-45d9-a1eb-3731d65da5c5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 3, 2020

Manufacturers
FDA

Servier Pharmaceuticals

DUNS: 116608503

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pegaspargase

PRODUCT DETAILS

NDC Product Code72694-313
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationINTRAVENOUS
Effective DateAugust 3, 2020
Generic NamePegaspargase

INGREDIENTS (7)

PEGASPARGASEActive
Quantity: 750 [iU] in 1 mL
Code: 7D96IR0PPM
Classification: ACTIB
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATEInactive
Code: 5QWK665956
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORMInactive
Code: GR686LBA74
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
LYOPHILIZED PEGASPARGASE - FDA Approval | MedPath